24/7 Market News Snapshot 08 September, 2025 – Talphera, Inc. Common Stock (NASDAQ:TLPH)

September 8, 2025

DENVER, Colo., 08 September, 2025 (www.247marketnews.com) – (Nasdaq:TLPH) are discussed in this article.
Talphera, Inc. (Nasdaq:TLPH) has recently attracted significant attention in the financial markets, with its shares opening at $0.58 and increasing by over 37% to a current price of $0.753, reflecting a surge in trading volume reaching 6.55 million shares. This notable rise is indicative of strong market sentiment and investor confidence in the company’s future potential.

In tandem with this market activity, Talphera has announced a critical financing initiative to enhance the development of its flagship product, Niyad™, an innovative anticoagulant designed for critically ill patients undergoing renal replacement therapy. The company has entered into securities purchase agreements with CorMedix Inc. and select institutional investors, with a total investment potential of up to $29 million. Following the initial closing of $17 million, Talphera could unlock an additional $12 million based on the achievement of specific milestones in the ongoing NEPHRO CRRT clinical study.

Vince Angotti, CEO of Talphera, expressed optimism about the implications of this funding, emphasizing that it positions the company favorably for progressing Niyad through its development stages. He acknowledged the steadfast support from both CorMedix and institutional investors, reinforcing Niyad’s potential impact in the acute care market.

As Talphera accelerates patient enrollment within the NEPHRO CRRT study, anticipated to conclude by the end of the year, this strategic investment not only fortifies the company’s financial base but also underscores its commitment to delivering innovative treatments that address urgent medical needs. The upcoming developments surrounding Niyad™ are poised to create significant advancements in therapeutic options for healthcare providers and patients alike.

Related news for (TLPH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.